tiprankstipranks
Trending News
More News >
Advertisement
Advertisement
Raymond James upgrades Dyne Therapeutics to Strong Buy into readout
PremiumThe FlyRaymond James upgrades Dyne Therapeutics to Strong Buy into readout
1M ago
Dyne Therapeutics upgraded to Strong Buy from Outperform at Raymond James
Premium
The Fly
Dyne Therapeutics upgraded to Strong Buy from Outperform at Raymond James
1M ago
Dyne Therapeutics Advances DMD Treatment with DYNE-251 Study
Premium
Company Announcements
Dyne Therapeutics Advances DMD Treatment with DYNE-251 Study
2M ago
Dyne Therapeutics Gains FDA Breakthrough Designation for DYNE-251
PremiumCompany AnnouncementsDyne Therapeutics Gains FDA Breakthrough Designation for DYNE-251
2M ago
Dyne Therapeutics announces FDA BTD to DYNE-251
Premium
The Fly
Dyne Therapeutics announces FDA BTD to DYNE-251
2M ago
Dyne Therapeutics: Strategic Advancements and Financial Stability Drive Buy Rating
Premium
Ratings
Dyne Therapeutics: Strategic Advancements and Financial Stability Drive Buy Rating
2M ago
Dyne Therapeutics reports Q2 EPS (97c), consensus (93c)
PremiumThe FlyDyne Therapeutics reports Q2 EPS (97c), consensus (93c)
2M ago
Dyne Therapeutics expects cash to fund operations into Q3 of 2027
Premium
The Fly
Dyne Therapeutics expects cash to fund operations into Q3 of 2027
2M ago
Dyne Therapeutics CEO buys $911K in common stock
Premium
The Fly
Dyne Therapeutics CEO buys $911K in common stock
3M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100